Global Integrated Radionuclide Medicine Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Integrated Radionuclide Medicine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Integrated radionuclide drugs are radiopharmaceutical systems that combine radionuclides with targeting molecules (such as peptides, antibodies, and small molecule ligands) through chemical linkage, resulting in both diagnostic and therapeutic capabilities. These drugs leverage the high affinity and selectivity of targeting molecules for specific lesions (such as tumor cells) to precisely deliver the radionuclide to the affected area, achieving the integration of "targeted imaging and targeted therapy," a so-called "theranostics" model. With advantages such as high specificity, low toxicity and side effects, and the ability to personalize treatment, these drugs are becoming a key area of convergence between precision medicine and nuclear medicine.
The global Integrated Radionuclide Medicine market size was estimated at USD 1280.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Integrated Radionuclide Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Integrated Radionuclide Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Integrated Radionuclide Medicine market.
Global Integrated Radionuclide Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Bayer AG
Curium
ITM Radiopharma
POINT Biopharma Global
Lantheus Holdings
Clarity Pharmaceuticals
RadioMedix
Telix Pharmaceuticals
ARTBIO
RayzeBio
Convergent Therapeutics
Mariana Oncology
Ratio Therapeutics
Advanced Accelerator Applications
Cardinal Health
GE HealthCare
Jubilant Pharma
IRE ELiT
NTP Radioisotopes
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Beijing Sinotau International Pharmaceutical Technology
Hexin Pharmaceutical Technology
Fulian Pharmaceuticals
Market Segmentation (by Type)
Diagnostic Radionuclide Drugs
Integrated Diagnostic and Therapeutic Radionuclide Drugs
Market Segmentation (by Application)
Healthcare Industry
Nuclear Medicine Industry
Biomedical Research and Development Industry
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Integrated Radionuclide Medicine Market
Overview of the regional outlook of the Integrated Radionuclide Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Integrated Radionuclide Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Integrated Radionuclide Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Integrated Radionuclide Medicine market size was estimated at USD 1280.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Integrated Radionuclide Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Integrated Radionuclide Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Integrated Radionuclide Medicine market.
Global Integrated Radionuclide Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Bayer AG
Curium
ITM Radiopharma
POINT Biopharma Global
Lantheus Holdings
Clarity Pharmaceuticals
RadioMedix
Telix Pharmaceuticals
ARTBIO
RayzeBio
Convergent Therapeutics
Mariana Oncology
Ratio Therapeutics
Advanced Accelerator Applications
Cardinal Health
GE HealthCare
Jubilant Pharma
IRE ELiT
NTP Radioisotopes
China Isotope & Radiation
Yantai Dongcheng Biochemicals
Beijing Sinotau International Pharmaceutical Technology
Hexin Pharmaceutical Technology
Fulian Pharmaceuticals
Market Segmentation (by Type)
Diagnostic Radionuclide Drugs
Integrated Diagnostic and Therapeutic Radionuclide Drugs
Market Segmentation (by Application)
Healthcare Industry
Nuclear Medicine Industry
Biomedical Research and Development Industry
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Integrated Radionuclide Medicine Market
Overview of the regional outlook of the Integrated Radionuclide Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Integrated Radionuclide Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Integrated Radionuclide Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Integrated Radionuclide Medicine
1.2 Key Market Segments
1.2.1 Integrated Radionuclide Medicine Segment by Type
1.2.2 Integrated Radionuclide Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INTEGRATED RADIONUCLIDE MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Integrated Radionuclide Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Integrated Radionuclide Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INTEGRATED RADIONUCLIDE MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Integrated Radionuclide Medicine Product Life Cycle
3.3 Global Integrated Radionuclide Medicine Sales by Manufacturers (2020-2025)
3.4 Global Integrated Radionuclide Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Integrated Radionuclide Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Integrated Radionuclide Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Integrated Radionuclide Medicine Market Competitive Situation and Trends
3.8.1 Integrated Radionuclide Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Integrated Radionuclide Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INTEGRATED RADIONUCLIDE MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Integrated Radionuclide Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INTEGRATED RADIONUCLIDE MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Integrated Radionuclide Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Integrated Radionuclide Medicine Market
5.7 ESG Ratings of Leading Companies
6 INTEGRATED RADIONUCLIDE MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Integrated Radionuclide Medicine Sales Market Share by Type (2020-2025)
6.3 Global Integrated Radionuclide Medicine Market Size by Type (2020-2025)
6.4 Global Integrated Radionuclide Medicine Price by Type (2020-2025)
7 INTEGRATED RADIONUCLIDE MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Integrated Radionuclide Medicine Market Sales by Application (2020-2025)
7.3 Global Integrated Radionuclide Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
8 INTEGRATED RADIONUCLIDE MEDICINE MARKET SALES BY REGION
8.1 Global Integrated Radionuclide Medicine Sales by Region
8.1.1 Global Integrated Radionuclide Medicine Sales by Region
8.1.2 Global Integrated Radionuclide Medicine Sales Market Share by Region
8.2 Global Integrated Radionuclide Medicine Market Size by Region
8.2.1 Global Integrated Radionuclide Medicine Market Size by Region
8.2.2 Global Integrated Radionuclide Medicine Market Size by Region
8.3 North America
8.3.1 North America Integrated Radionuclide Medicine Sales by Country
8.3.2 North America Integrated Radionuclide Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Integrated Radionuclide Medicine Sales by Country
8.4.2 Europe Integrated Radionuclide Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Integrated Radionuclide Medicine Sales by Region
8.5.2 Asia Pacific Integrated Radionuclide Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Integrated Radionuclide Medicine Sales by Country
8.6.2 South America Integrated Radionuclide Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Integrated Radionuclide Medicine Sales by Region
8.7.2 Middle East and Africa Integrated Radionuclide Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INTEGRATED RADIONUCLIDE MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Integrated Radionuclide Medicine by Region(2020-2025)
9.2 Global Integrated Radionuclide Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Integrated Radionuclide Medicine Production
9.4.1 North America Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.4.2 North America Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Integrated Radionuclide Medicine Production
9.5.1 Europe Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Integrated Radionuclide Medicine Production (2020-2025)
9.6.1 Japan Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Integrated Radionuclide Medicine Production (2020-2025)
9.7.1 China Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.7.2 China Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Integrated Radionuclide Medicine Product Overview
10.1.3 Novartis Integrated Radionuclide Medicine Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer AG
10.2.1 Bayer AG Basic Information
10.2.2 Bayer AG Integrated Radionuclide Medicine Product Overview
10.2.3 Bayer AG Integrated Radionuclide Medicine Product Market Performance
10.2.4 Bayer AG Business Overview
10.2.5 Bayer AG SWOT Analysis
10.2.6 Bayer AG Recent Developments
10.3 Curium
10.3.1 Curium Basic Information
10.3.2 Curium Integrated Radionuclide Medicine Product Overview
10.3.3 Curium Integrated Radionuclide Medicine Product Market Performance
10.3.4 Curium Business Overview
10.3.5 Curium SWOT Analysis
10.3.6 Curium Recent Developments
10.4 ITM Radiopharma
10.4.1 ITM Radiopharma Basic Information
10.4.2 ITM Radiopharma Integrated Radionuclide Medicine Product Overview
10.4.3 ITM Radiopharma Integrated Radionuclide Medicine Product Market Performance
10.4.4 ITM Radiopharma Business Overview
10.4.5 ITM Radiopharma Recent Developments
10.5 POINT Biopharma Global
10.5.1 POINT Biopharma Global Basic Information
10.5.2 POINT Biopharma Global Integrated Radionuclide Medicine Product Overview
10.5.3 POINT Biopharma Global Integrated Radionuclide Medicine Product Market Performance
10.5.4 POINT Biopharma Global Business Overview
10.5.5 POINT Biopharma Global Recent Developments
10.6 Lantheus Holdings
10.6.1 Lantheus Holdings Basic Information
10.6.2 Lantheus Holdings Integrated Radionuclide Medicine Product Overview
10.6.3 Lantheus Holdings Integrated Radionuclide Medicine Product Market Performance
10.6.4 Lantheus Holdings Business Overview
10.6.5 Lantheus Holdings Recent Developments
10.7 Clarity Pharmaceuticals
10.7.1 Clarity Pharmaceuticals Basic Information
10.7.2 Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.7.3 Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.7.4 Clarity Pharmaceuticals Business Overview
10.7.5 Clarity Pharmaceuticals Recent Developments
10.8 RadioMedix
10.8.1 RadioMedix Basic Information
10.8.2 RadioMedix Integrated Radionuclide Medicine Product Overview
10.8.3 RadioMedix Integrated Radionuclide Medicine Product Market Performance
10.8.4 RadioMedix Business Overview
10.8.5 RadioMedix Recent Developments
10.9 Telix Pharmaceuticals
10.9.1 Telix Pharmaceuticals Basic Information
10.9.2 Telix Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.9.3 Telix Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.9.4 Telix Pharmaceuticals Business Overview
10.9.5 Telix Pharmaceuticals Recent Developments
10.10 ARTBIO
10.10.1 ARTBIO Basic Information
10.10.2 ARTBIO Integrated Radionuclide Medicine Product Overview
10.10.3 ARTBIO Integrated Radionuclide Medicine Product Market Performance
10.10.4 ARTBIO Business Overview
10.10.5 ARTBIO Recent Developments
10.11 RayzeBio
10.11.1 RayzeBio Basic Information
10.11.2 RayzeBio Integrated Radionuclide Medicine Product Overview
10.11.3 RayzeBio Integrated Radionuclide Medicine Product Market Performance
10.11.4 RayzeBio Business Overview
10.11.5 RayzeBio Recent Developments
10.12 Convergent Therapeutics
10.12.1 Convergent Therapeutics Basic Information
10.12.2 Convergent Therapeutics Integrated Radionuclide Medicine Product Overview
10.12.3 Convergent Therapeutics Integrated Radionuclide Medicine Product Market Performance
10.12.4 Convergent Therapeutics Business Overview
10.12.5 Convergent Therapeutics Recent Developments
10.13 Mariana Oncology
10.13.1 Mariana Oncology Basic Information
10.13.2 Mariana Oncology Integrated Radionuclide Medicine Product Overview
10.13.3 Mariana Oncology Integrated Radionuclide Medicine Product Market Performance
10.13.4 Mariana Oncology Business Overview
10.13.5 Mariana Oncology Recent Developments
10.14 Ratio Therapeutics
10.14.1 Ratio Therapeutics Basic Information
10.14.2 Ratio Therapeutics Integrated Radionuclide Medicine Product Overview
10.14.3 Ratio Therapeutics Integrated Radionuclide Medicine Product Market Performance
10.14.4 Ratio Therapeutics Business Overview
10.14.5 Ratio Therapeutics Recent Developments
10.15 Advanced Accelerator Applications
10.15.1 Advanced Accelerator Applications Basic Information
10.15.2 Advanced Accelerator Applications Integrated Radionuclide Medicine Product Overview
10.15.3 Advanced Accelerator Applications Integrated Radionuclide Medicine Product Market Performance
10.15.4 Advanced Accelerator Applications Business Overview
10.15.5 Advanced Accelerator Applications Recent Developments
10.16 Cardinal Health
10.16.1 Cardinal Health Basic Information
10.16.2 Cardinal Health Integrated Radionuclide Medicine Product Overview
10.16.3 Cardinal Health Integrated Radionuclide Medicine Product Market Performance
10.16.4 Cardinal Health Business Overview
10.16.5 Cardinal Health Recent Developments
10.17 GE HealthCare
10.17.1 GE HealthCare Basic Information
10.17.2 GE HealthCare Integrated Radionuclide Medicine Product Overview
10.17.3 GE HealthCare Integrated Radionuclide Medicine Product Market Performance
10.17.4 GE HealthCare Business Overview
10.17.5 GE HealthCare Recent Developments
10.18 Jubilant Pharma
10.18.1 Jubilant Pharma Basic Information
10.18.2 Jubilant Pharma Integrated Radionuclide Medicine Product Overview
10.18.3 Jubilant Pharma Integrated Radionuclide Medicine Product Market Performance
10.18.4 Jubilant Pharma Business Overview
10.18.5 Jubilant Pharma Recent Developments
10.19 IRE ELiT
10.19.1 IRE ELiT Basic Information
10.19.2 IRE ELiT Integrated Radionuclide Medicine Product Overview
10.19.3 IRE ELiT Integrated Radionuclide Medicine Product Market Performance
10.19.4 IRE ELiT Business Overview
10.19.5 IRE ELiT Recent Developments
10.20 NTP Radioisotopes
10.20.1 NTP Radioisotopes Basic Information
10.20.2 NTP Radioisotopes Integrated Radionuclide Medicine Product Overview
10.20.3 NTP Radioisotopes Integrated Radionuclide Medicine Product Market Performance
10.20.4 NTP Radioisotopes Business Overview
10.20.5 NTP Radioisotopes Recent Developments
10.21 China Isotope and Radiation
10.21.1 China Isotope and Radiation Basic Information
10.21.2 China Isotope and Radiation Integrated Radionuclide Medicine Product Overview
10.21.3 China Isotope and Radiation Integrated Radionuclide Medicine Product Market Performance
10.21.4 China Isotope and Radiation Business Overview
10.21.5 China Isotope and Radiation Recent Developments
10.22 Yantai Dongcheng Biochemicals
10.22.1 Yantai Dongcheng Biochemicals Basic Information
10.22.2 Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Overview
10.22.3 Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Market Performance
10.22.4 Yantai Dongcheng Biochemicals Business Overview
10.22.5 Yantai Dongcheng Biochemicals Recent Developments
10.23 Beijing Sinotau International Pharmaceutical Technology
10.23.1 Beijing Sinotau International Pharmaceutical Technology Basic Information
10.23.2 Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
10.23.3 Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Market Performance
10.23.4 Beijing Sinotau International Pharmaceutical Technology Business Overview
10.23.5 Beijing Sinotau International Pharmaceutical Technology Recent Developments
10.24 Hexin Pharmaceutical Technology
10.24.1 Hexin Pharmaceutical Technology Basic Information
10.24.2 Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
10.24.3 Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Market Performance
10.24.4 Hexin Pharmaceutical Technology Business Overview
10.24.5 Hexin Pharmaceutical Technology Recent Developments
10.25 Fulian Pharmaceuticals
10.25.1 Fulian Pharmaceuticals Basic Information
10.25.2 Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.25.3 Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.25.4 Fulian Pharmaceuticals Business Overview
10.25.5 Fulian Pharmaceuticals Recent Developments
11 INTEGRATED RADIONUCLIDE MEDICINE MARKET FORECAST BY REGION
11.1 Global Integrated Radionuclide Medicine Market Size Forecast
11.2 Global Integrated Radionuclide Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Integrated Radionuclide Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Integrated Radionuclide Medicine Market Size Forecast by Region
11.2.4 South America Integrated Radionuclide Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Integrated Radionuclide Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Integrated Radionuclide Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Integrated Radionuclide Medicine by Type (2026-2035)
12.1.2 Global Integrated Radionuclide Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Integrated Radionuclide Medicine by Type (2026-2035)
12.2 Global Integrated Radionuclide Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Integrated Radionuclide Medicine Sales (K MT) Forecast by Application
12.2.2 Global Integrated Radionuclide Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Integrated Radionuclide Medicine
1.2 Key Market Segments
1.2.1 Integrated Radionuclide Medicine Segment by Type
1.2.2 Integrated Radionuclide Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INTEGRATED RADIONUCLIDE MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Integrated Radionuclide Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Integrated Radionuclide Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INTEGRATED RADIONUCLIDE MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Integrated Radionuclide Medicine Product Life Cycle
3.3 Global Integrated Radionuclide Medicine Sales by Manufacturers (2020-2025)
3.4 Global Integrated Radionuclide Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Integrated Radionuclide Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Integrated Radionuclide Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Integrated Radionuclide Medicine Market Competitive Situation and Trends
3.8.1 Integrated Radionuclide Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Integrated Radionuclide Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INTEGRATED RADIONUCLIDE MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Integrated Radionuclide Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INTEGRATED RADIONUCLIDE MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Integrated Radionuclide Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Integrated Radionuclide Medicine Market
5.7 ESG Ratings of Leading Companies
6 INTEGRATED RADIONUCLIDE MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Integrated Radionuclide Medicine Sales Market Share by Type (2020-2025)
6.3 Global Integrated Radionuclide Medicine Market Size by Type (2020-2025)
6.4 Global Integrated Radionuclide Medicine Price by Type (2020-2025)
7 INTEGRATED RADIONUCLIDE MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Integrated Radionuclide Medicine Market Sales by Application (2020-2025)
7.3 Global Integrated Radionuclide Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
8 INTEGRATED RADIONUCLIDE MEDICINE MARKET SALES BY REGION
8.1 Global Integrated Radionuclide Medicine Sales by Region
8.1.1 Global Integrated Radionuclide Medicine Sales by Region
8.1.2 Global Integrated Radionuclide Medicine Sales Market Share by Region
8.2 Global Integrated Radionuclide Medicine Market Size by Region
8.2.1 Global Integrated Radionuclide Medicine Market Size by Region
8.2.2 Global Integrated Radionuclide Medicine Market Size by Region
8.3 North America
8.3.1 North America Integrated Radionuclide Medicine Sales by Country
8.3.2 North America Integrated Radionuclide Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Integrated Radionuclide Medicine Sales by Country
8.4.2 Europe Integrated Radionuclide Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Integrated Radionuclide Medicine Sales by Region
8.5.2 Asia Pacific Integrated Radionuclide Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Integrated Radionuclide Medicine Sales by Country
8.6.2 South America Integrated Radionuclide Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Integrated Radionuclide Medicine Sales by Region
8.7.2 Middle East and Africa Integrated Radionuclide Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INTEGRATED RADIONUCLIDE MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Integrated Radionuclide Medicine by Region(2020-2025)
9.2 Global Integrated Radionuclide Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Integrated Radionuclide Medicine Production
9.4.1 North America Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.4.2 North America Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Integrated Radionuclide Medicine Production
9.5.1 Europe Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Integrated Radionuclide Medicine Production (2020-2025)
9.6.1 Japan Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Integrated Radionuclide Medicine Production (2020-2025)
9.7.1 China Integrated Radionuclide Medicine Production Growth Rate (2020-2025)
9.7.2 China Integrated Radionuclide Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novartis
10.1.1 Novartis Basic Information
10.1.2 Novartis Integrated Radionuclide Medicine Product Overview
10.1.3 Novartis Integrated Radionuclide Medicine Product Market Performance
10.1.4 Novartis Business Overview
10.1.5 Novartis SWOT Analysis
10.1.6 Novartis Recent Developments
10.2 Bayer AG
10.2.1 Bayer AG Basic Information
10.2.2 Bayer AG Integrated Radionuclide Medicine Product Overview
10.2.3 Bayer AG Integrated Radionuclide Medicine Product Market Performance
10.2.4 Bayer AG Business Overview
10.2.5 Bayer AG SWOT Analysis
10.2.6 Bayer AG Recent Developments
10.3 Curium
10.3.1 Curium Basic Information
10.3.2 Curium Integrated Radionuclide Medicine Product Overview
10.3.3 Curium Integrated Radionuclide Medicine Product Market Performance
10.3.4 Curium Business Overview
10.3.5 Curium SWOT Analysis
10.3.6 Curium Recent Developments
10.4 ITM Radiopharma
10.4.1 ITM Radiopharma Basic Information
10.4.2 ITM Radiopharma Integrated Radionuclide Medicine Product Overview
10.4.3 ITM Radiopharma Integrated Radionuclide Medicine Product Market Performance
10.4.4 ITM Radiopharma Business Overview
10.4.5 ITM Radiopharma Recent Developments
10.5 POINT Biopharma Global
10.5.1 POINT Biopharma Global Basic Information
10.5.2 POINT Biopharma Global Integrated Radionuclide Medicine Product Overview
10.5.3 POINT Biopharma Global Integrated Radionuclide Medicine Product Market Performance
10.5.4 POINT Biopharma Global Business Overview
10.5.5 POINT Biopharma Global Recent Developments
10.6 Lantheus Holdings
10.6.1 Lantheus Holdings Basic Information
10.6.2 Lantheus Holdings Integrated Radionuclide Medicine Product Overview
10.6.3 Lantheus Holdings Integrated Radionuclide Medicine Product Market Performance
10.6.4 Lantheus Holdings Business Overview
10.6.5 Lantheus Holdings Recent Developments
10.7 Clarity Pharmaceuticals
10.7.1 Clarity Pharmaceuticals Basic Information
10.7.2 Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.7.3 Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.7.4 Clarity Pharmaceuticals Business Overview
10.7.5 Clarity Pharmaceuticals Recent Developments
10.8 RadioMedix
10.8.1 RadioMedix Basic Information
10.8.2 RadioMedix Integrated Radionuclide Medicine Product Overview
10.8.3 RadioMedix Integrated Radionuclide Medicine Product Market Performance
10.8.4 RadioMedix Business Overview
10.8.5 RadioMedix Recent Developments
10.9 Telix Pharmaceuticals
10.9.1 Telix Pharmaceuticals Basic Information
10.9.2 Telix Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.9.3 Telix Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.9.4 Telix Pharmaceuticals Business Overview
10.9.5 Telix Pharmaceuticals Recent Developments
10.10 ARTBIO
10.10.1 ARTBIO Basic Information
10.10.2 ARTBIO Integrated Radionuclide Medicine Product Overview
10.10.3 ARTBIO Integrated Radionuclide Medicine Product Market Performance
10.10.4 ARTBIO Business Overview
10.10.5 ARTBIO Recent Developments
10.11 RayzeBio
10.11.1 RayzeBio Basic Information
10.11.2 RayzeBio Integrated Radionuclide Medicine Product Overview
10.11.3 RayzeBio Integrated Radionuclide Medicine Product Market Performance
10.11.4 RayzeBio Business Overview
10.11.5 RayzeBio Recent Developments
10.12 Convergent Therapeutics
10.12.1 Convergent Therapeutics Basic Information
10.12.2 Convergent Therapeutics Integrated Radionuclide Medicine Product Overview
10.12.3 Convergent Therapeutics Integrated Radionuclide Medicine Product Market Performance
10.12.4 Convergent Therapeutics Business Overview
10.12.5 Convergent Therapeutics Recent Developments
10.13 Mariana Oncology
10.13.1 Mariana Oncology Basic Information
10.13.2 Mariana Oncology Integrated Radionuclide Medicine Product Overview
10.13.3 Mariana Oncology Integrated Radionuclide Medicine Product Market Performance
10.13.4 Mariana Oncology Business Overview
10.13.5 Mariana Oncology Recent Developments
10.14 Ratio Therapeutics
10.14.1 Ratio Therapeutics Basic Information
10.14.2 Ratio Therapeutics Integrated Radionuclide Medicine Product Overview
10.14.3 Ratio Therapeutics Integrated Radionuclide Medicine Product Market Performance
10.14.4 Ratio Therapeutics Business Overview
10.14.5 Ratio Therapeutics Recent Developments
10.15 Advanced Accelerator Applications
10.15.1 Advanced Accelerator Applications Basic Information
10.15.2 Advanced Accelerator Applications Integrated Radionuclide Medicine Product Overview
10.15.3 Advanced Accelerator Applications Integrated Radionuclide Medicine Product Market Performance
10.15.4 Advanced Accelerator Applications Business Overview
10.15.5 Advanced Accelerator Applications Recent Developments
10.16 Cardinal Health
10.16.1 Cardinal Health Basic Information
10.16.2 Cardinal Health Integrated Radionuclide Medicine Product Overview
10.16.3 Cardinal Health Integrated Radionuclide Medicine Product Market Performance
10.16.4 Cardinal Health Business Overview
10.16.5 Cardinal Health Recent Developments
10.17 GE HealthCare
10.17.1 GE HealthCare Basic Information
10.17.2 GE HealthCare Integrated Radionuclide Medicine Product Overview
10.17.3 GE HealthCare Integrated Radionuclide Medicine Product Market Performance
10.17.4 GE HealthCare Business Overview
10.17.5 GE HealthCare Recent Developments
10.18 Jubilant Pharma
10.18.1 Jubilant Pharma Basic Information
10.18.2 Jubilant Pharma Integrated Radionuclide Medicine Product Overview
10.18.3 Jubilant Pharma Integrated Radionuclide Medicine Product Market Performance
10.18.4 Jubilant Pharma Business Overview
10.18.5 Jubilant Pharma Recent Developments
10.19 IRE ELiT
10.19.1 IRE ELiT Basic Information
10.19.2 IRE ELiT Integrated Radionuclide Medicine Product Overview
10.19.3 IRE ELiT Integrated Radionuclide Medicine Product Market Performance
10.19.4 IRE ELiT Business Overview
10.19.5 IRE ELiT Recent Developments
10.20 NTP Radioisotopes
10.20.1 NTP Radioisotopes Basic Information
10.20.2 NTP Radioisotopes Integrated Radionuclide Medicine Product Overview
10.20.3 NTP Radioisotopes Integrated Radionuclide Medicine Product Market Performance
10.20.4 NTP Radioisotopes Business Overview
10.20.5 NTP Radioisotopes Recent Developments
10.21 China Isotope and Radiation
10.21.1 China Isotope and Radiation Basic Information
10.21.2 China Isotope and Radiation Integrated Radionuclide Medicine Product Overview
10.21.3 China Isotope and Radiation Integrated Radionuclide Medicine Product Market Performance
10.21.4 China Isotope and Radiation Business Overview
10.21.5 China Isotope and Radiation Recent Developments
10.22 Yantai Dongcheng Biochemicals
10.22.1 Yantai Dongcheng Biochemicals Basic Information
10.22.2 Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Overview
10.22.3 Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Market Performance
10.22.4 Yantai Dongcheng Biochemicals Business Overview
10.22.5 Yantai Dongcheng Biochemicals Recent Developments
10.23 Beijing Sinotau International Pharmaceutical Technology
10.23.1 Beijing Sinotau International Pharmaceutical Technology Basic Information
10.23.2 Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
10.23.3 Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Market Performance
10.23.4 Beijing Sinotau International Pharmaceutical Technology Business Overview
10.23.5 Beijing Sinotau International Pharmaceutical Technology Recent Developments
10.24 Hexin Pharmaceutical Technology
10.24.1 Hexin Pharmaceutical Technology Basic Information
10.24.2 Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
10.24.3 Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Market Performance
10.24.4 Hexin Pharmaceutical Technology Business Overview
10.24.5 Hexin Pharmaceutical Technology Recent Developments
10.25 Fulian Pharmaceuticals
10.25.1 Fulian Pharmaceuticals Basic Information
10.25.2 Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Overview
10.25.3 Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Market Performance
10.25.4 Fulian Pharmaceuticals Business Overview
10.25.5 Fulian Pharmaceuticals Recent Developments
11 INTEGRATED RADIONUCLIDE MEDICINE MARKET FORECAST BY REGION
11.1 Global Integrated Radionuclide Medicine Market Size Forecast
11.2 Global Integrated Radionuclide Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Integrated Radionuclide Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Integrated Radionuclide Medicine Market Size Forecast by Region
11.2.4 South America Integrated Radionuclide Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Integrated Radionuclide Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Integrated Radionuclide Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Integrated Radionuclide Medicine by Type (2026-2035)
12.1.2 Global Integrated Radionuclide Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Integrated Radionuclide Medicine by Type (2026-2035)
12.2 Global Integrated Radionuclide Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Integrated Radionuclide Medicine Sales (K MT) Forecast by Application
12.2.2 Global Integrated Radionuclide Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Integrated Radionuclide Medicine Market Size by Type (M USD)
Table 4. Global Integrated Radionuclide Medicine Market Size by Application
Table 5. Integrated Radionuclide Medicine Market Size Comparison by Region (M USD)
Table 6. Global Integrated Radionuclide Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Integrated Radionuclide Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Integrated Radionuclide Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Integrated Radionuclide Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrated Radionuclide Medicine as of 2025)
Table 11. Global Market Integrated Radionuclide Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Integrated Radionuclide Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Integrated Radionuclide Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Integrated Radionuclide Medicine Sales by Type (K MT)
Table 27. Global Integrated Radionuclide Medicine Market Size by Type (M USD)
Table 28. Global Integrated Radionuclide Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Integrated Radionuclide Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Integrated Radionuclide Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Integrated Radionuclide Medicine Market Share by Type (2020-2025)
Table 32. Global Integrated Radionuclide Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Integrated Radionuclide Medicine Sales (K MT) by Application
Table 34. Global Integrated Radionuclide Medicine Market Size by Application
Table 35. Global Integrated Radionuclide Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Integrated Radionuclide Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Integrated Radionuclide Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Integrated Radionuclide Medicine Market Share by Application (2020-2025)
Table 39. Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Integrated Radionuclide Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025)
Table 44. North America Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Integrated Radionuclide Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Integrated Radionuclide Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Integrated Radionuclide Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Integrated Radionuclide Medicine Product Overview
Table 64. Novartis Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Bayer AG Basic Information
Table 69. Bayer AG Integrated Radionuclide Medicine Product Overview
Table 70. Bayer AG Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bayer AG Business Overview
Table 72. Bayer AG SWOT Analysis
Table 73. Bayer AG Recent Developments
Table 74. Curium Basic Information
Table 75. Curium Integrated Radionuclide Medicine Product Overview
Table 76. Curium Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Curium Business Overview
Table 78. Curium SWOT Analysis
Table 79. Curium Recent Developments
Table 80. ITM Radiopharma Basic Information
Table 81. ITM Radiopharma Integrated Radionuclide Medicine Product Overview
Table 82. ITM Radiopharma Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ITM Radiopharma Business Overview
Table 84. ITM Radiopharma Recent Developments
Table 85. POINT Biopharma Global Basic Information
Table 86. POINT Biopharma Global Integrated Radionuclide Medicine Product Overview
Table 87. POINT Biopharma Global Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. POINT Biopharma Global Business Overview
Table 89. POINT Biopharma Global Recent Developments
Table 90. Lantheus Holdings Basic Information
Table 91. Lantheus Holdings Integrated Radionuclide Medicine Product Overview
Table 92. Lantheus Holdings Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Lantheus Holdings Business Overview
Table 94. Lantheus Holdings Recent Developments
Table 95. Clarity Pharmaceuticals Basic Information
Table 96. Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 97. Clarity Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Clarity Pharmaceuticals Business Overview
Table 99. Clarity Pharmaceuticals Recent Developments
Table 100. RadioMedix Basic Information
Table 101. RadioMedix Integrated Radionuclide Medicine Product Overview
Table 102. RadioMedix Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. RadioMedix Business Overview
Table 104. RadioMedix Recent Developments
Table 105. Telix Pharmaceuticals Basic Information
Table 106. Telix Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 107. Telix Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Telix Pharmaceuticals Business Overview
Table 109. Telix Pharmaceuticals Recent Developments
Table 110. ARTBIO Basic Information
Table 111. ARTBIO Integrated Radionuclide Medicine Product Overview
Table 112. ARTBIO Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. ARTBIO Business Overview
Table 114. ARTBIO Recent Developments
Table 115. RayzeBio Basic Information
Table 116. RayzeBio Integrated Radionuclide Medicine Product Overview
Table 117. RayzeBio Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. RayzeBio Business Overview
Table 119. RayzeBio Recent Developments
Table 120. Convergent Therapeutics Basic Information
Table 121. Convergent Therapeutics Integrated Radionuclide Medicine Product Overview
Table 122. Convergent Therapeutics Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Convergent Therapeutics Business Overview
Table 124. Convergent Therapeutics Recent Developments
Table 125. Mariana Oncology Basic Information
Table 126. Mariana Oncology Integrated Radionuclide Medicine Product Overview
Table 127. Mariana Oncology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Mariana Oncology Business Overview
Table 129. Mariana Oncology Recent Developments
Table 130. Ratio Therapeutics Basic Information
Table 131. Ratio Therapeutics Integrated Radionuclide Medicine Product Overview
Table 132. Ratio Therapeutics Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ratio Therapeutics Business Overview
Table 134. Ratio Therapeutics Recent Developments
Table 135. Advanced Accelerator Applications Basic Information
Table 136. Advanced Accelerator Applications Integrated Radionuclide Medicine Product Overview
Table 137. Advanced Accelerator Applications Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Advanced Accelerator Applications Business Overview
Table 139. Advanced Accelerator Applications Recent Developments
Table 140. Cardinal Health Basic Information
Table 141. Cardinal Health Integrated Radionuclide Medicine Product Overview
Table 142. Cardinal Health Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Cardinal Health Business Overview
Table 144. Cardinal Health Recent Developments
Table 145. GE HealthCare Basic Information
Table 146. GE HealthCare Integrated Radionuclide Medicine Product Overview
Table 147. GE HealthCare Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. GE HealthCare Business Overview
Table 149. GE HealthCare Recent Developments
Table 150. Jubilant Pharma Basic Information
Table 151. Jubilant Pharma Integrated Radionuclide Medicine Product Overview
Table 152. Jubilant Pharma Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Jubilant Pharma Business Overview
Table 154. Jubilant Pharma Recent Developments
Table 155. IRE ELiT Basic Information
Table 156. IRE ELiT Integrated Radionuclide Medicine Product Overview
Table 157. IRE ELiT Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. IRE ELiT Business Overview
Table 159. IRE ELiT Recent Developments
Table 160. NTP Radioisotopes Basic Information
Table 161. NTP Radioisotopes Integrated Radionuclide Medicine Product Overview
Table 162. NTP Radioisotopes Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. NTP Radioisotopes Business Overview
Table 164. NTP Radioisotopes Recent Developments
Table 165. China Isotope and Radiation Basic Information
Table 166. China Isotope and Radiation Integrated Radionuclide Medicine Product Overview
Table 167. China Isotope and Radiation Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Isotope and Radiation Business Overview
Table 169. China Isotope and Radiation Recent Developments
Table 170. Yantai Dongcheng Biochemicals Basic Information
Table 171. Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Overview
Table 172. Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Yantai Dongcheng Biochemicals Business Overview
Table 174. Yantai Dongcheng Biochemicals Recent Developments
Table 175. Beijing Sinotau International Pharmaceutical Technology Basic Information
Table 176. Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
Table 177. Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Beijing Sinotau International Pharmaceutical Technology Business Overview
Table 179. Beijing Sinotau International Pharmaceutical Technology Recent Developments
Table 180. Hexin Pharmaceutical Technology Basic Information
Table 181. Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
Table 182. Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Hexin Pharmaceutical Technology Business Overview
Table 184. Hexin Pharmaceutical Technology Recent Developments
Table 185. Fulian Pharmaceuticals Basic Information
Table 186. Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 187. Fulian Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Fulian Pharmaceuticals Business Overview
Table 189. Fulian Pharmaceuticals Recent Developments
Table 190. Global Integrated Radionuclide Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 191. Global Integrated Radionuclide Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 193. North America Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 195. Europe Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Integrated Radionuclide Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 197. Asia Pacific Integrated Radionuclide Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 199. South America Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Integrated Radionuclide Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 203. Global Integrated Radionuclide Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Integrated Radionuclide Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 205. Global Integrated Radionuclide Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 206. Global Integrated Radionuclide Medicine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Integrated Radionuclide Medicine Market Size by Type (M USD)
Table 4. Global Integrated Radionuclide Medicine Market Size by Application
Table 5. Integrated Radionuclide Medicine Market Size Comparison by Region (M USD)
Table 6. Global Integrated Radionuclide Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Integrated Radionuclide Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Integrated Radionuclide Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Integrated Radionuclide Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrated Radionuclide Medicine as of 2025)
Table 11. Global Market Integrated Radionuclide Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Integrated Radionuclide Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Integrated Radionuclide Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Integrated Radionuclide Medicine Sales by Type (K MT)
Table 27. Global Integrated Radionuclide Medicine Market Size by Type (M USD)
Table 28. Global Integrated Radionuclide Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Integrated Radionuclide Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Integrated Radionuclide Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Integrated Radionuclide Medicine Market Share by Type (2020-2025)
Table 32. Global Integrated Radionuclide Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Integrated Radionuclide Medicine Sales (K MT) by Application
Table 34. Global Integrated Radionuclide Medicine Market Size by Application
Table 35. Global Integrated Radionuclide Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Integrated Radionuclide Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Integrated Radionuclide Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Integrated Radionuclide Medicine Market Share by Application (2020-2025)
Table 39. Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Integrated Radionuclide Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025)
Table 44. North America Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Integrated Radionuclide Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Integrated Radionuclide Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Integrated Radionuclide Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Integrated Radionuclide Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Integrated Radionuclide Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Integrated Radionuclide Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Integrated Radionuclide Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Integrated Radionuclide Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novartis Basic Information
Table 63. Novartis Integrated Radionuclide Medicine Product Overview
Table 64. Novartis Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novartis Business Overview
Table 66. Novartis SWOT Analysis
Table 67. Novartis Recent Developments
Table 68. Bayer AG Basic Information
Table 69. Bayer AG Integrated Radionuclide Medicine Product Overview
Table 70. Bayer AG Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Bayer AG Business Overview
Table 72. Bayer AG SWOT Analysis
Table 73. Bayer AG Recent Developments
Table 74. Curium Basic Information
Table 75. Curium Integrated Radionuclide Medicine Product Overview
Table 76. Curium Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Curium Business Overview
Table 78. Curium SWOT Analysis
Table 79. Curium Recent Developments
Table 80. ITM Radiopharma Basic Information
Table 81. ITM Radiopharma Integrated Radionuclide Medicine Product Overview
Table 82. ITM Radiopharma Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. ITM Radiopharma Business Overview
Table 84. ITM Radiopharma Recent Developments
Table 85. POINT Biopharma Global Basic Information
Table 86. POINT Biopharma Global Integrated Radionuclide Medicine Product Overview
Table 87. POINT Biopharma Global Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. POINT Biopharma Global Business Overview
Table 89. POINT Biopharma Global Recent Developments
Table 90. Lantheus Holdings Basic Information
Table 91. Lantheus Holdings Integrated Radionuclide Medicine Product Overview
Table 92. Lantheus Holdings Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Lantheus Holdings Business Overview
Table 94. Lantheus Holdings Recent Developments
Table 95. Clarity Pharmaceuticals Basic Information
Table 96. Clarity Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 97. Clarity Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Clarity Pharmaceuticals Business Overview
Table 99. Clarity Pharmaceuticals Recent Developments
Table 100. RadioMedix Basic Information
Table 101. RadioMedix Integrated Radionuclide Medicine Product Overview
Table 102. RadioMedix Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. RadioMedix Business Overview
Table 104. RadioMedix Recent Developments
Table 105. Telix Pharmaceuticals Basic Information
Table 106. Telix Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 107. Telix Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Telix Pharmaceuticals Business Overview
Table 109. Telix Pharmaceuticals Recent Developments
Table 110. ARTBIO Basic Information
Table 111. ARTBIO Integrated Radionuclide Medicine Product Overview
Table 112. ARTBIO Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. ARTBIO Business Overview
Table 114. ARTBIO Recent Developments
Table 115. RayzeBio Basic Information
Table 116. RayzeBio Integrated Radionuclide Medicine Product Overview
Table 117. RayzeBio Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. RayzeBio Business Overview
Table 119. RayzeBio Recent Developments
Table 120. Convergent Therapeutics Basic Information
Table 121. Convergent Therapeutics Integrated Radionuclide Medicine Product Overview
Table 122. Convergent Therapeutics Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Convergent Therapeutics Business Overview
Table 124. Convergent Therapeutics Recent Developments
Table 125. Mariana Oncology Basic Information
Table 126. Mariana Oncology Integrated Radionuclide Medicine Product Overview
Table 127. Mariana Oncology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Mariana Oncology Business Overview
Table 129. Mariana Oncology Recent Developments
Table 130. Ratio Therapeutics Basic Information
Table 131. Ratio Therapeutics Integrated Radionuclide Medicine Product Overview
Table 132. Ratio Therapeutics Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Ratio Therapeutics Business Overview
Table 134. Ratio Therapeutics Recent Developments
Table 135. Advanced Accelerator Applications Basic Information
Table 136. Advanced Accelerator Applications Integrated Radionuclide Medicine Product Overview
Table 137. Advanced Accelerator Applications Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Advanced Accelerator Applications Business Overview
Table 139. Advanced Accelerator Applications Recent Developments
Table 140. Cardinal Health Basic Information
Table 141. Cardinal Health Integrated Radionuclide Medicine Product Overview
Table 142. Cardinal Health Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Cardinal Health Business Overview
Table 144. Cardinal Health Recent Developments
Table 145. GE HealthCare Basic Information
Table 146. GE HealthCare Integrated Radionuclide Medicine Product Overview
Table 147. GE HealthCare Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. GE HealthCare Business Overview
Table 149. GE HealthCare Recent Developments
Table 150. Jubilant Pharma Basic Information
Table 151. Jubilant Pharma Integrated Radionuclide Medicine Product Overview
Table 152. Jubilant Pharma Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Jubilant Pharma Business Overview
Table 154. Jubilant Pharma Recent Developments
Table 155. IRE ELiT Basic Information
Table 156. IRE ELiT Integrated Radionuclide Medicine Product Overview
Table 157. IRE ELiT Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. IRE ELiT Business Overview
Table 159. IRE ELiT Recent Developments
Table 160. NTP Radioisotopes Basic Information
Table 161. NTP Radioisotopes Integrated Radionuclide Medicine Product Overview
Table 162. NTP Radioisotopes Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. NTP Radioisotopes Business Overview
Table 164. NTP Radioisotopes Recent Developments
Table 165. China Isotope and Radiation Basic Information
Table 166. China Isotope and Radiation Integrated Radionuclide Medicine Product Overview
Table 167. China Isotope and Radiation Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. China Isotope and Radiation Business Overview
Table 169. China Isotope and Radiation Recent Developments
Table 170. Yantai Dongcheng Biochemicals Basic Information
Table 171. Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Product Overview
Table 172. Yantai Dongcheng Biochemicals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Yantai Dongcheng Biochemicals Business Overview
Table 174. Yantai Dongcheng Biochemicals Recent Developments
Table 175. Beijing Sinotau International Pharmaceutical Technology Basic Information
Table 176. Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
Table 177. Beijing Sinotau International Pharmaceutical Technology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Beijing Sinotau International Pharmaceutical Technology Business Overview
Table 179. Beijing Sinotau International Pharmaceutical Technology Recent Developments
Table 180. Hexin Pharmaceutical Technology Basic Information
Table 181. Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Product Overview
Table 182. Hexin Pharmaceutical Technology Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 183. Hexin Pharmaceutical Technology Business Overview
Table 184. Hexin Pharmaceutical Technology Recent Developments
Table 185. Fulian Pharmaceuticals Basic Information
Table 186. Fulian Pharmaceuticals Integrated Radionuclide Medicine Product Overview
Table 187. Fulian Pharmaceuticals Integrated Radionuclide Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 188. Fulian Pharmaceuticals Business Overview
Table 189. Fulian Pharmaceuticals Recent Developments
Table 190. Global Integrated Radionuclide Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 191. Global Integrated Radionuclide Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 192. North America Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 193. North America Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 194. Europe Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 195. Europe Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 196. Asia Pacific Integrated Radionuclide Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 197. Asia Pacific Integrated Radionuclide Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 198. South America Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 199. South America Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 200. Middle East and Africa Integrated Radionuclide Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 201. Middle East and Africa Integrated Radionuclide Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 202. Global Integrated Radionuclide Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 203. Global Integrated Radionuclide Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 204. Global Integrated Radionuclide Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 205. Global Integrated Radionuclide Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 206. Global Integrated Radionuclide Medicine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Integrated Radionuclide Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Integrated Radionuclide Medicine Market Size (M USD), 2025-2035
Figure 5. Global Integrated Radionuclide Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Integrated Radionuclide Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Integrated Radionuclide Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Integrated Radionuclide Medicine Product Life Cycle
Figure 13. Integrated Radionuclide Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Integrated Radionuclide Medicine Revenue Share by Manufacturers in 2025
Figure 15. Integrated Radionuclide Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Integrated Radionuclide Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Integrated Radionuclide Medicine Revenue in 2025
Figure 18. Industry Chain Map of Integrated Radionuclide Medicine
Figure 19. Global Integrated Radionuclide Medicine Market PEST Analysis
Figure 20. Global Integrated Radionuclide Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Integrated Radionuclide Medicine Market Share by Type
Figure 27. Sales Market Share of Integrated Radionuclide Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Integrated Radionuclide Medicine by Type in 2025
Figure 29. Market Share of Integrated Radionuclide Medicine by Type (2020-2025)
Figure 30. Market Share of Integrated Radionuclide Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Integrated Radionuclide Medicine Market Share by Application
Figure 33. Global Integrated Radionuclide Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Integrated Radionuclide Medicine Sales Market Share by Application in 2025
Figure 35. Global Integrated Radionuclide Medicine Market Share by Application (2020-2025)
Figure 36. Global Integrated Radionuclide Medicine Market Share by Application in 2025
Figure 37. Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Integrated Radionuclide Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025)
Figure 40. North America Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 43. North America Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 45. U.S. Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Integrated Radionuclide Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Integrated Radionuclide Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Integrated Radionuclide Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Integrated Radionuclide Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 53. Europe Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 55. Germany Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Integrated Radionuclide Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Integrated Radionuclide Medicine Market Size by Region in 2024
Figure 68. China Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 79. South America Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 80. South America Integrated Radionuclide Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 82. Brazil Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Integrated Radionuclide Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Integrated Radionuclide Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Integrated Radionuclide Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Integrated Radionuclide Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Integrated Radionuclide Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Integrated Radionuclide Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Integrated Radionuclide Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Integrated Radionuclide Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Integrated Radionuclide Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Integrated Radionuclide Medicine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Integrated Radionuclide Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Integrated Radionuclide Medicine Market Size (M USD), 2025-2035
Figure 5. Global Integrated Radionuclide Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Integrated Radionuclide Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Integrated Radionuclide Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Integrated Radionuclide Medicine Product Life Cycle
Figure 13. Integrated Radionuclide Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Integrated Radionuclide Medicine Revenue Share by Manufacturers in 2025
Figure 15. Integrated Radionuclide Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Integrated Radionuclide Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Integrated Radionuclide Medicine Revenue in 2025
Figure 18. Industry Chain Map of Integrated Radionuclide Medicine
Figure 19. Global Integrated Radionuclide Medicine Market PEST Analysis
Figure 20. Global Integrated Radionuclide Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Integrated Radionuclide Medicine Market Share by Type
Figure 27. Sales Market Share of Integrated Radionuclide Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Integrated Radionuclide Medicine by Type in 2025
Figure 29. Market Share of Integrated Radionuclide Medicine by Type (2020-2025)
Figure 30. Market Share of Integrated Radionuclide Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Integrated Radionuclide Medicine Market Share by Application
Figure 33. Global Integrated Radionuclide Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Integrated Radionuclide Medicine Sales Market Share by Application in 2025
Figure 35. Global Integrated Radionuclide Medicine Market Share by Application (2020-2025)
Figure 36. Global Integrated Radionuclide Medicine Market Share by Application in 2025
Figure 37. Global Integrated Radionuclide Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Integrated Radionuclide Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Integrated Radionuclide Medicine Market Size by Region (2020-2025)
Figure 40. North America Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 43. North America Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 45. U.S. Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Integrated Radionuclide Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Integrated Radionuclide Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Integrated Radionuclide Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Integrated Radionuclide Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 53. Europe Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 55. Germany Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Integrated Radionuclide Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Integrated Radionuclide Medicine Market Size by Region in 2024
Figure 68. China Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 79. South America Integrated Radionuclide Medicine Sales Market Share by Country in 2024
Figure 80. South America Integrated Radionuclide Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Integrated Radionuclide Medicine Market Size by Country in 2024
Figure 82. Brazil Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Integrated Radionuclide Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Integrated Radionuclide Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Integrated Radionuclide Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Integrated Radionuclide Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Integrated Radionuclide Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Integrated Radionuclide Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Integrated Radionuclide Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Integrated Radionuclide Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Integrated Radionuclide Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Integrated Radionuclide Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Integrated Radionuclide Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Integrated Radionuclide Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Integrated Radionuclide Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Integrated Radionuclide Medicine Market Share Forecast by Application (2026-2035)
